Chemren Bio-Engineering Co., Ltd.

Products > Others > > LY335979
Product name : LY335979
Item : CRY905
CAS : 167354-41-8
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→


Details:
Description of:LY335979
LY335979 significantly enhanced the survival of mice implanted with Pgp-expressing murine leukemia (P388/ADR) when administered in combination with either daunorubicin, doxorubicin or etoposide. Coadministration of LY335979 with paclitaxel compared to paclitaxel alone significantly reduced the tumor mass of the Pgp-expressing UCLA-P3.003VLB lung carcinoma in a xenograph model. 

Theoretical analysis:LY335979
M.Wt: 527.6
Formula: C32H31F2N3O2
Solubility: Unknown
Purity: >99%
Storage: at -20
CAS No: 167354-41-8

Availability and price:LY335979
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : 
sales@chemrenpharm.com
Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days


Related Products :
2-ketodoxapram
2-ketodoxapram
GNE0877
GNE0877
CBL0137
CBL0137
Carteolol hydrochloride
Carteolol hydrochloride
UNC1999
UNC1999
Fenofibrate
Fenofibrate
SGC0946
SGC0946
Pilaralisib(XL-147)
Pilaralisib(XL-147)

Online service

点击这里给我发消息